Presentation TCT 2013 TCT-35. Changes In Bioabsorbable Scaffold Geometry After Kissing Balloon Inflation In Bifurcated Coronary Lesions Presenter: Pedro Martin Lorenzo October 29, 2013
Presentation TCT 2013 TCT-40. BASELINE BLEEDING RISK AND ARTERIAL ACCESS SITE PRACTICE IN RELATION TO PROCEDURAL OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION Presenter: Mamas Mamas October 29, 2013
Presentation TCT 2013 Interim results of the JUPITER Registry on long-term performance and safety of the Transapical JenaValve Presenter: Stephan Ensminger October 29, 2013
Presentation TCT 2013 TCT-108. Baseline Mitral Regurgitation Does Not Affect 30 Day to Two Year Mortality after Transcatheter Aortic-Valve Implantation (TAVI). A Report on 576 Patients from the Swedi... Presenter: Andreas R?ck October 29, 2013
Presentation TCT 2013 Transcatheter Orthotopic Aortic Valve Implantation In Sheep: Chronic Survival And Valve Performance Evaluation Presenter: Jeannot Potvin October 29, 2013
Presentation TCT 2013 TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents Presenter: Peter Smits October 29, 2013
Presentation TCT 2013 TCT-51. Prognostic impact of chronic total occlusion in patients with different severity of coronary artery disease - A report from the Swedish Coronary Angiography and... Presenter: Truls R?munddal October 29, 2013
Presentation TCT 2013 Non-cellular Therapies in the Clinic: SDF-1 and Other Agents Presenter: Marc Penn October 29, 2013
Presentation TCT 2013 Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS Presenter: Michael Kutcher October 29, 2013
Presentation TCT 2013 Return to the Two Cases: Panel Discussion on Treatment Strategies (and Case Conclusions) Presenter: Isaac George October 29, 2013